Screening and Characterization of Antibiotic Producing Organisms from Waste Dump Soil Sample
- 1 Department of Applied Microbiology and Brewing, Nnamdi Azikiwe University, Awka, Nigeria
- 2 Department of Biological Sciences, Godfrey Okoye University, Enugu, Enugu State, Nigeria
- 3 Department of Microbiology, Novena University, Ogume, Delta State, Nigeria
- 4 Department of Applied Microbiology and Brewing, Nnamdi Azikiwe University, Awka, Nigeria
- 5 Department of Microbiology, Renaissance University, Ugbawka, Enugu State, Nigeria
- 6 Department of Pharmaceutical Microbiology and Biotechnology, Faculty of Pharmaceutical Sciences, Chukwuemeka Odumegwu Ojukwu University, Igbariam, Anambra State, Nigeria
Abstract
This study was designed to screen and characterize antibiotic producing bacteria and fungi from soil samples from a waste dump site in Enugu. The molecular characterization of the isolates was performed by using Zymo Research Quick-DNA fungi/bacteria miniprep kit. The bacteria isolates were Providencia stuartii , Providencia alcalifaciens. Bacillus sp. , Streptococcus sp. , Micrococcus sp. , and Staphylococcus sp while Aspergillus fumigatus and Aspergillus niger were fungal isolates. The efficacy of the Crude Extract (CE) of the antibiotics produced was tested against species of Staphylococcus aureus and Escherichia coli . The CE of antibiotics when compared with a conventional antibiotic (Ciprofloxacin) showed lower antimicrobial activity. The minimum inhibitory concentration of the crude extracts ranged between 12.5% and 25% concentrations while the minimum bactericidal concentration ranged from 25% and 50% concentrations. The findings suggest that these organisms have the potential to produce antibiotics and could be harnessed by pharmaceutical industries for the production of newer antibiotics.
- Baltz, R.H. (2006) Marcel Faber Roundtable: Is Our Antibiotic Pipeline Unproductive Because of Starvation, Constipation or Lack of Inspiration? Journal of Industrial Microbiology and Biotechnology, 33, 507-513. https://doi.org/10.1007/s10295-005-0077-9
- Molinari, G. (2009) Natural Products in Drug Discovery, Present Status and Perspectives. Pharmaceutical Biotechnology, 655, 13-27. https://doi.org/10.1007/978-1-4419-1132-2_2
- Makut, M. and Owolewa, O. (2011) Antibiotic-Producing Fungi Present in the Soil Environment of Keffi Metropolis, Nasarawa State, Nigeria. Trakia Journal of Sciences, 9, 33-39.
- Berdy, J. (2005) Bioactive Metabolites, a Personal View. Journal of Antibotics, 58, 1-26. https://doi.org/10.1038/ja.2005.1
- Fernando, P. (2006) The Historical Delivery of Antibiotics from Microbial Natural Products—Can History Repeat? Biochemical Pharmacology, 71, 981-990. https://doi.org/10.1016/j.bcp.2005.10.010
- Wohlleben, W., Mast, Y., Stegmann, E. and Ziemert, N. (2016) Antibiotic Drug Discovery. Microbial Biotechnology, 9, 541-548. https://doi.org/10.1111/1751-7915.12388
- Brock, T.D. and Madigan, M.T. (1991) Biology of Microorganisms. 6th Edition, Prentice-Hall International Incorporated, USA, 198-223.
- Adegboye, M.F. and Babalola, O.O. (2013) Actinomycetes: A Yet Inexhaustive Source of Bioactive Secondary Metabolites. In: Mendez-Vilas, A., Ed., Microbial Pathogens and Strategies for Combating Them: Science, Technology and Education, Formatex, Nassarawa State, 786-795.
- Bhardwaj, A., Chaman, S. and Verma, S. (2017) Production of Antibacterial Agent from Fungi Isolated from Pharmaceutical Soil Sample by Fermentation under Optimized Conditions. Asian Journal of Pharmaceutical and Clinical Research, 10, 110-115. https://doi.org/10.22159/ajpcr.2017.v10i7.18258
- Coates, A.R., Halls, G. and Hu, Y. (2011) Novel Classes of Antibiotics or More of the Same? British Journal of Pharmacology, 163, 184-194. https://doi.org/10.1111/j.1476-5381.2011.01250.x
- Laxminarayan, R. (2014) Antibiotic Effectiveness: Balancing Conservation against Innovation. Science, 345, 1299-1301. https://doi.org/10.1126/science.1254163
- Wernli, D., Haustein, T., Conly, J., Carmeli, Y., Kickbusch, I. and Harbarth, S. (2011) A Call for Action: The Application of the International Health Regulations to the Global Threat of Antimicrobial Resistance. PLoS Medicine, 8, e1001022. https://doi.org/10.1371/journal.pmed.1001022